[SIME] YoY Annualized Quarter Result on 30-Sep-2016 [#1]

Stock
[SIME] SIME DARBY BHD
Announcement Date
25-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2017
Quarter
30-Sep-2016 [#1]
Profit Trend
QoQ- -13.79%
YoY- 61.61%
Quarter Report
Latest QR
Upcoming QR
SIME's Result
SIME's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 37,904,000 35,380,000 32,576,000 27,736,000 40,692,000 40,497,696 42,336,584 -1.82%
PBT 1,408,000 1,324,000 1,504,000 1,248,000 1,844,000 2,699,680 2,681,072 -10.17%
Tax -372,000 -372,000 4,072,000 1,068,000 -424,000 -593,092 -616,280 -8.06%
NP 1,036,000 952,000 5,576,000 2,316,000 1,420,000 2,106,588 2,064,792 -10.85%
-
NP to SH 984,000 900,000 5,264,000 2,088,000 1,292,000 2,002,776 1,955,956 -10.81%
-
Tax Rate 26.42% 28.10% -270.74% -85.58% 22.99% 21.97% 22.99% -
Total Cost 36,868,000 34,428,000 27,000,000 25,420,000 39,272,000 38,391,108 40,271,792 -1.46%
-
Net Worth 14,213,753 14,213,753 38,561,670 31,642,857 31,970,013 28,914,168 27,513,138 -10.41%
Dividend
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Div - - - - - - - -
Div Payout % - - - - - - - -
Equity
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Net Worth 14,213,753 14,213,753 38,561,670 31,642,857 31,970,013 28,914,168 27,513,138 -10.41%
NOSH 6,800,839 6,800,839 6,800,839 6,328,571 6,207,769 6,061,670 6,007,235 2.08%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin 2.73% 2.69% 17.12% 8.35% 3.49% 5.20% 4.88% -
ROE 6.92% 6.33% 13.65% 6.60% 4.04% 6.93% 7.11% -
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 557.34 520.23 478.99 438.27 655.50 668.09 704.76 -3.83%
EPS 14.40 13.20 77.20 32.80 20.80 33.04 32.56 -12.70%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
NAPS 2.09 2.09 5.67 5.00 5.15 4.77 4.58 -12.25%
Adjusted Per Share Value based on latest NOSH - 6,328,571
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 556.42 519.37 478.20 407.15 597.34 594.49 621.49 -1.82%
EPS 14.44 13.21 77.27 30.65 18.97 29.40 28.71 -10.81%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
NAPS 2.0865 2.0865 5.6607 4.6451 4.6931 4.2445 4.0388 -10.41%
Price Multiplier on Financial Quarter End Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 -
Price 2.25 2.61 9.02 7.65 7.79 9.15 9.50 -
P/RPS 0.40 0.50 1.88 1.75 1.19 1.37 1.35 -18.34%
P/EPS 15.55 19.72 11.65 23.19 37.43 27.69 29.18 -9.95%
EY 6.43 5.07 8.58 4.31 2.67 3.61 3.43 11.03%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 1.08 1.25 1.59 1.53 1.51 1.92 2.07 -10.27%
Price Multiplier on Announcement Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 26/11/19 21/11/18 16/11/17 25/11/16 26/11/15 28/11/14 29/11/13 -
Price 2.29 2.40 9.00 8.10 8.06 9.68 9.65 -
P/RPS 0.41 0.46 1.88 1.85 1.23 1.45 1.37 -18.20%
P/EPS 15.83 18.14 11.63 24.55 38.73 29.30 29.64 -9.92%
EY 6.32 5.51 8.60 4.07 2.58 3.41 3.37 11.04%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 1.10 1.15 1.59 1.62 1.57 2.03 2.11 -10.28%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment